Why Services-Led FDI Is Changing Investment in the UAE

Foreign direct investment is undergoing a fundamental shift.

For decades, investment models have been driven by large capital commitments, long timelines, and delayed economic impact. But today, a new approach is emerging—one that prioritizes execution over capital.

👉 Services-Led FDI

This model enables international companies to enter new markets by focusing first on:

  • market entry
  • revenue generation
  • operational deployment

Only after these foundations are established do companies move toward localization and manufacturing.

Why this matters for the UAE

The UAE is uniquely positioned to lead this transformation.

With strong institutional frameworks, advanced digital infrastructure, and a clear focus on industrial growth, the country offers an environment where companies can not only invest—but execute.

Initiatives such as Make It In The Emirates and the In-Country Value (ICV) program further support this shift toward real economic activity, not just capital inflow.

From concept to execution

At 360Disruption, we apply a structured model that translates global innovation into local impact:

Global Innovation → UAE Entry → Revenue → Localization → Manufacturing

This approach reduces risk, accelerates time-to-market, and creates measurable outcomes such as job creation and industrial capability.

Read the full article

To explore the full framework and global context behind services-led FDI, read the complete article here:

👉 https://360disruption.com/services-led-fdi-why-services-led-fdi-is-reshaping-global-investment/


 

Comments

Post a Comment

Popular posts from this blog

Why 360Disruption Is the Partner of Choice for Health-tech Expansion in the Gulf

Image
In today’s competitive global health-tech landscape, entering new markets requires more than a regulatory checklist or a polished investor deck. It requires local traction, commercial validation, and trusted partnerships that can turn plans into performance. That’s where 360Disruption comes in. At 360Disruption, we don’t offer advisory in a vacuum. We execute. Whether you’re a U.S.-based company seeking to expand to the UAE, or a visionary startup looking for a trusted partner to bring your solution to life, we offer a pathway grounded in reality and built for scale Three Paths to Market Entry. One Strategic Engine. Every company we work with is different. Some are still testing product-market fit. Others are ready to scale. A few simply need the right on-the-ground team to carry the commercial flag. That’s why we built our platform around three adaptable tracks: 1. Incubation We work with early-stage companies or first-time entrants into the region to de-risk market entry, validate lo...
Read more

Launching a Healthtech Venture in the UAE: A Strategic Guide by 360Disruption

Image
A Strategic Launch Guide by @360disruption The United Arab Emirates (UAE) is quickly becoming one of the most promising launchpads for global healthtech innovation. With forward-thinking leadership, robust infrastructure, and a commitment to becoming a regional healthcare powerhouse, the UAE offers unparalleled opportunities for startups and scale-ups alike. At 360Disruption, we’ve helped companies from the U.S. and Europe navigate this ecosystem — and this guide captures what it takes to enter and scale across the Emirates. The Rise of Healthtech in the UAE: Why It Matters Across the UAE, government-driven healthcare modernization is accelerating. From Abu Dhabi’s academic health initiatives to Dubai’s smart health infrastructure , the country is positioning itself as a global healthtech hub. Key drivers include: Dubai Academic Health Corporation (DAHC) and Dubai Health Authority (DHA) initiatives such as NABIDH (Unified Medical Records) and Sheryan (Smart Licensing). Abu Dhabi...
Read more

Why the UAE’s Medical Device Classification System is a Game-Changer for U.S. Healthtech Companies

Image
Why the UAE’s Medical Device Classification System is a Game-Changer for U.S. Healthtech Companies   The United Arab Emirates (UAE) has quietly built one of the world’s most innovation-friendly pathways for medical device companies—and now, more than ever, U.S.-based healthtech startups and scaleups should take notice. Unlike the FDA’s formal and risk-heavy classification system, the UAE’s Ministry of Health and Prevention (MOHAP) offers a flexible, product-specific, and internationally harmonized framework that accelerates market access, reduces cost, and creates entry into a health-conscious, tech-forward region. This is not just an alternative to the U.S. regulatory maze—it’s a springboard into the broader Middle East, Africa, and Asia.   UAE vs. FDA: Key Differences at a Glance Criteria FDA (USA) MOHAP / UAE Classification Class I, II, III Class I, IIa, IIb, III (EU MDR aligned) Approach Risk-based Risk-based + product-specific Timeline 12–36 months Weeks to classification...
Read more